762 F. Supp. 2d 694 - Kellogg v. Wyeth’s Empirical Analysis

Citation profile

5 federal appellate · 3 district · 6 state decisions

Most-quoted passages

The sentences later courts lift from this opinion, ranked by how many decisions quote each — the parts of the opinion doing the work. These counts are smaller than the citation total above because most of the 24 citing decisions cite the case generally; a passage count includes only decisions quoting that exact language verbatim.

1. “[I]t is reasonably foreseeable that a physician will rely upon a brand name manufacturer’s representations — or the absence of representations — about the risk of side effects of its drug, when deciding to prescribe the drug for a patient, regardless of whether the pharmacist fills the prescription with a generic form of the drug.”

   2 later decisions quote this exact passage
   e.g. Wyeth, Inc. v. Danny Weeks and Vicki Weeks · 856 F. Supp. 2d 904 - Esposito v. Eli Lilly & Co.

2. “duty of care in disseminating product information extends to those patients who are injured by generic metoclopramide as a result of prescriptions written in reliance on [the brand-name manufacturer's] product information for Reglan.”

   1 later decision quote this exact passage
   e.g. Wyeth, Inc. v. Danny Weeks and Vicki Weeks

3. “her doctors relied on inaccurate and misleading information –- or the absence of accurate information -– from [the brand-name manufacturer] concerning the risks and effects of long-term use of [metoclopramide].”

   1 later decision quote this exact passage
   e.g. Wyeth, Inc. v. Danny Weeks and Vicki Weeks